Kazakhstan vs Sur: Previously treated cases tested for RR-/MDR-TB
Kazakhstan
100.0%
in 2024
Sur
62.0%
in 2024
Kazakhstan rank
1st
Sur rank
2nd
Previously treated cases tested for RR-/MDR-TB over time
- Kazakhstan
- Sur
How they compare
Kazakhstan currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Kazakhstan's figure about 1.6 times Sur's.
The two have swapped places 4 times across 16 shared years of data; in 2008 it was Kazakhstan ahead.
Kazakhstan ranks 1st and Sur ranks 2nd of 180 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kazakhstan | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 47.5% | 21.5% | 26.0% | Kazakhstan |
| 2010s | 91.4% | 53.0% | 38.4% | Kazakhstan |
| 2020s | 100.0% | 78.4% | 21.6% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Kazakhstan or Sur?
- Kazakhstan, at 100.0% against 62.0% in Sur as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Kazakhstan and Sur?
- 38.0%, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Sur?
- 16 years are reported by both, from 2008 to 2024.
- How do Kazakhstan and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Kazakhstan ranks 1st and Sur ranks 2nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.